Drugmakers take sides in Amgen, Regeneron fight over antibody patents

Drugmakers take sides in Amgen, Regeneron fight over antibody patents

Source: 
BioPharma Dive
snippet: 

The nearly decade-long patent feud between Amgen and rivals Sanofi and Regeneron has divided the biopharmaceutical industry, with drugmakers taking different sides in a U.S. Supreme Court case that could have far-reaching effects.